Page last updated: 2024-10-17

choline and Lymph Node Metastasis

choline has been researched along with Lymph Node Metastasis in 103 studies

Research Excerpts

ExcerptRelevanceReference
"We aimed to assess the diagnostic accuracy of C-11 choline and C-11 acetate positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging in bladder cancer (BC) patients through a systematic review and meta-analysis."8.98Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. ( Kim, IJ; Kim, K; Kim, SJ; Koo, PJ; Pak, K, 2018)
"A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer."7.81Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015)
"The aim of this study was to evaluate the potential role of C-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard."7.8111C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. ( Bianchi, L; Castellucci, P; Ceci, F; Colletti, PM; Eugenio, B; Fanti, S; Graziani, T; Martorana, G; Pultrone, C; Rubello, D; Schiavina, R, 2015)
"Prostate carcinoma is the most common cancer in men."5.46Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017)
"A total of 72 patients with nodal prostate cancer relapse after primary therapy underwent pelvic and/or retroperitoneal salvage lymph node dissection."5.40Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014)
"11C-choline PET was very effective in detecting lymph node metastases in the mediastinum originating from NSCLC, with a sensitivity of 100%."5.31Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. ( Hara, T; Inagaki, K; Kosaka, N; Morita, T, 2000)
"We aimed to assess the diagnostic accuracy of C-11 choline and C-11 acetate positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging in bladder cancer (BC) patients through a systematic review and meta-analysis."4.98Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. ( Kim, IJ; Kim, K; Kim, SJ; Koo, PJ; Pak, K, 2018)
" Choline PET/CT (positron emission tomography/computed tomography) and magnetic resonance imaging (MRI) have been used for the evaluation of lymph node metastasis in patients with prostate cancer for the past decade."4.98Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer. ( Huang, SM; Li, YF; Lin, ZC; Yang, Y; Yin, L; Yue, JL, 2018)
"A 65-year-old patient with prostate adenocarcinoma was explored by 18F-fluorocholine (FCH) PET/CT for pretreatment staging because of a high risk of prostate cancer."3.81Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT. ( Allard, JB; Cornelis, F; De Clermont, H; Pasticier, G; Pinaquy, JB, 2015)
"A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer."3.81Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer. ( De Clermont, H; Fernandez, P; Parrens, M; Pasticier, G; Pinaquy, JB, 2015)
"The aim of this study was to evaluate the potential role of C-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard."3.8111C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. ( Bianchi, L; Castellucci, P; Ceci, F; Colletti, PM; Eugenio, B; Fanti, S; Graziani, T; Martorana, G; Pultrone, C; Rubello, D; Schiavina, R, 2015)
" Staging with (18)F-fluorocholine PET/CT ((18)F-FCH PET/CT) demonstrated lymph node metastasis."3.79Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time. ( Cimitan, M; Fettich, J; Gubina, B; Hodolič, M; Maffione, AM; Rubello, D, 2013)
"To assess the relationship between breast cancer subtypes and choline detection by using in vivo proton magnetic resonance (MR) spectroscopy and to assess the feasibility of proton MR spectroscopy in the study of axillary lymph node metastases."3.71Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. ( Tse, GM; Yang, WT; Yeung, DK, 2002)
"Limited pelvic nodal relapse of prostatic cancer is a paramount challenge for locoregional salvage treatments."2.90Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07). ( Beckendorf, V; Buthaud, X; Campion, L; Créhange, G; De Laroche, G; Denis, F; Goineau, A; Hasbini, A; Lagrange, JL; Latorzeff, I; Loos, G; Palpacuer, C; Pasquier, D; Pommier, P; Rio, E; Sargos, P; Silva, M; Supiot, S; Vaugier, L, 2019)
"Localized very high-risk prostate cancer (VHR PCa) has long suffered from the inex-istence of good lymph node staging methods other than invasive surgery, as computed tomogra-phy has low sensitivity for nodal disease."2.82Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer. ( Barbé, Y; Botelho, F; Cathelineau, X; Colandrea, G; Dias, N; Macek, P; Rodriguez-Sanchez, L, 2022)
"Twelve prostate cancer patients (nine staging, three re-staging) were included."2.80BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study). ( Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R, 2015)
"Lung cancers were analysed visually and semiquantitatively using the ratio of tumour-to-normal radioactivity (T/N ratio) and standardized uptake value (SUV)."2.71A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer. ( Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H, 2003)
"Oligorecurrent prostate cancer with exclusive nodal involvement represents a common state of disease, amenable to local therapy."2.61Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer. ( Castellucci, P; Ceci, F; Di Muzio, N; Fodor, A; Hoyer, M; Incerti, E; Ingrosso, G; Jereczek-Fossa, BA; Lancia, A; Ost, P; Picchio, M, 2019)
"Choline PET/CT has shown limitations for the detection of primary prostate cancer and nodal metastatic disease, mainly due to limited sensitivity and specificity."2.49Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer. ( Gocke, Ch; Hildebrandt, G; Krause, BJ; Kuhnt, T; Kurth, J; Schwarzenböck, SM, 2013)
"The role of PET imaging in prostate cancer is gradually evolving but still remains within the experimental realm."2.44Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse? ( Cascini, GL; Greco, C; Tamburrini, O, 2008)
"We identified 124 consecutive prostate cancer patients from 2008 to 2018 with a solitary oligorecurrent metastatic lesion on positron emission tomography imaging who were treated with metastasis-directed therapy without androgen deprivation therapy from the Mayo Clinic C-11 choline registry."1.72Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. ( Ahmed, ME; Andrews, JR; Boorjian, SA; Britton, C; Joshi, VB; Karnes, RJ; Kendi, AT; Kwon, ED; Phillips, R; Sharma, V; Sood, A; Stish, B; Tollefson, MK, 2022)
"We identified all men with prostate cancer undergoing FCH PET/CT for initial staging followed by RALP and ePLND at Skåne University Hospital between 2015 and 2018."1.62A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node ( Amidi, J; Anand, A; Bjartell, A; Bjöersdorff, M; Jiborn, T; Kjölhede, H; Puterman, C; Soller, W; Trägårdh, E, 2021)
"In patients with high-risk prostate cancer, FCH PET and FCH PET/WBMRI depict significantly more metastatic lesions than do conventional imaging and WBMRI."1.48 ( Berlin, A; Ghai, S; Halankar, J; Jhaveri, KS; Metser, U; Murphy, G; Tau, N, 2018)
"Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment."1.48Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. ( Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S, 2018)
"Post-treatment 11C-Choline-PET showed metabolic complete response in 17 metastases (44,7%), partial response in 9 metastases (38%)."1.4611C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. ( Chiti, A; D'Agostino, GR; Di Brina, L; Franzese, C; Lopci, E; Mancosu, P; Navarria, P; Scorsetti, M; Tomatis, S, 2017)
"11C-choline-PET/CT-guided HTT is safe and effective in the treatment of LN relapses of prostate cancer in previously treated patients."1.46Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer. ( Berardi, G; Busnardo, E; Calandrino, R; Cozzarini, C; Dell'Oca, I; Di Muzio, NG; Fiorino, C; Fodor, A; Gianolli, L; Incerti, E; Kirienko, M; Mangili, P; Pasetti, M; Picchio, M, 2017)
"Prostate carcinoma is the most common cancer in men."1.46Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017)
"Two patients died of prostate cancer."1.42Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. ( Bergstralh, EJ; Cheville, JC; DiMonte, G; Karnes, RJ; Kwon, ED; Lowe, VJ; Murphy, CR; Mynderse, LA, 2015)
"Choline kinase is upregulated in prostate cancer, resulting in increased (18)F-fluoromethylcholine uptake."1.42Quantification of 18F-fluorocholine kinetics in patients with prostate cancer. ( Boellaard, R; Hendrikse, NH; Hoekstra, OS; Lammertsma, AA; Oprea-Lager, DE; Schuit, RC; Schwarte, LA; van den Eertwegh, AJ; van Moorselaar, RJ; Verwer, EE; Windhorst, AD, 2015)
"multi-parametric MRI in the prostate cancer relapse."1.42(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015)
"A total of 72 patients with nodal prostate cancer relapse after primary therapy underwent pelvic and/or retroperitoneal salvage lymph node dissection."1.40Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. ( Drendel, V; Grosu, AL; Henne, K; Hölz, S; Jandausch, A; Jilg, CA; Krauss, T; Reske, SN; Rischke, HC; Schultze-Seemann, W; Vach, W; Weber, WA; Wieser, G, 2014)
"Documented local recurrence and pelvic LN and bone metastases was present in 61 of 87 (70."1.40Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. ( Froemming, AT; Hagen, CE; Kawashima, A; Kitajima, K; Murphy, RC; Nathan, MA; Takahashi, N, 2014)
"To evaluate, in prostate cancer (PCa) patients the potential of (11)C-choline PET/CT as a guide to helical tomotherapy (HTT) of lymph-node (LN) relapses with simultaneous integrated boost (SIB)."1.40(11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients. ( Berardi, G; Busnardo, E; Crivellaro, C; Di Muzio, N; Fiorino, C; Fodor, A; Gianolli, L; Giovacchini, G; Incerti, E; Kirienko, M; Messa, C; Picchio, M, 2014)
"Salvage surgery for prostate cancer is a fascinating but controversial approach."1.40First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches. ( Bianchi, L; Borghesi, M; Brunocilla, E; Cevenini, M; Concetti, S; Fanti, S; Gentile, G; Martorana, G; Molinaroli, E; Nanni, C; Schiavina, R, 2014)
"1%), by requesting 15 frequent items of adverse events from the Common-Terminology-Criteria for Adverse Events Version 4."1.40Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer. ( Grosu, AL; Henne, K; Jilg, CA; Kirste, S; Leifert, A; Rischke, HC; Schlager, D; Schnell, D; Schultze-Seemann, W; Volegova-Neher, N; Wieser, G, 2014)
"Patients with prostate cancer with prostate specific antigen (PSA) levels between 20 and 99 ng/mL and/or Gleason score 8-10 tumours, planned for treatment with curative intent based on routine staging with a negative or inconclusive bone scan, were further investigated with a (18)F-fluorocholine and a (18)F-fluoride PET/CT."1.38Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2012)
"Twenty high-risk prostate cancer patients underwent a pelvic SPECT acquisition following a transrectal ultrasound guided injection of 99mTc-Nanocoll into the prostate."1.38Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT. ( Buchegger, F; Chouiter, A; Dipasquale, G; Miralbell, R; Namy, S; Ratib, O; Steiner, C; Vees, H; Velazquez, M; Zilli, T, 2012)
"Fourteen patients with prostate cancer underwent DWI at 1."1.37Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer. ( Beer, AJ; Eiber, M; Gaa, J; Ganter, C; Holzapfel, K; Krause, BJ; Kübler, H; Maurer, T; Souvatzoglou, M; Weirich, G; Wester, HJ, 2011)
"62 patients with stage 1 cervical cancer were scanned at 1."1.36Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. ( Bridges, J; DeSouza, NM; Giles, S; Ind, T; Morgan, VA; Payne, GS; Schmidt, M, 2010)
"ER negative breast cancer was more aggressive, with larger tumor size, more non-mass-type enhancement lesions, and a higher percentage showing enlarged axillary nodes on MRI."1.35Estrogen receptor and breast MR imaging features: a correlation study. ( Baek, HM; Chen, JH; Nalcioglu, O; Su, MY, 2008)
"Choline peak in vivo is a specific but not sensitive marker of malignancy."1.33Evaluation of spectral selected press sequence in breast lesion characterization. ( Bao, RX; Liu, PF; Lu, H; Sun, F, 2006)
"Prostate cancer is known for its difficulties in preoperative staging of pelvic lymph nodes by conventional imaging techniques."1.32Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. ( de Jong, IJ; Elsinga, PH; Mensink, HJ; Pruim, J; Vaalburg, W, 2003)
"11C-choline PET was very effective in detecting lymph node metastases in the mediastinum originating from NSCLC, with a sensitivity of 100%."1.31Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. ( Hara, T; Inagaki, K; Kosaka, N; Morita, T, 2000)
"More brain metastases were detected with (11)C-CHOL PET (23/23) than with (18)F-FDG PET (3/23)."1.31Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. ( Elsinga, PH; Groen, HJ; Pieterman, RM; Pruim, J; Que, TH; Vaalburg, W; van Putten, JW; Willemsen, AT, 2002)

Research

Studies (103)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (1.94)18.2507
2000's24 (23.30)29.6817
2010's73 (70.87)24.3611
2020's4 (3.88)2.80

Authors

AuthorsStudies
Bjöersdorff, M2
Puterman, C2
Oddstig, J1
Amidi, J2
Zackrisson, S1
Kjölhede, H4
Bjartell, A2
Wollmer, P1
Trägårdh, E2
Andrews, JR1
Ahmed, ME1
Sharma, V1
Britton, C1
Stish, B1
Phillips, R1
Kendi, AT1
Joshi, VB1
Sood, A1
Tollefson, MK1
Boorjian, SA1
Karnes, RJ4
Kwon, ED3
Dias, N1
Colandrea, G1
Botelho, F1
Rodriguez-Sanchez, L1
Barbé, Y1
Macek, P1
Cathelineau, X1
Anand, A1
Soller, W1
Jiborn, T1
Bouman-Wammes, EW1
van Dodewaard-De Jong, JM1
Dahele, M1
Cysouw, MCF1
Hoekstra, OS2
van Moorselaar, RJA1
Piet, MAH1
Verberne, HJ1
Bins, AD1
Verheul, HMW1
Slotman, BJ1
Oprea-Lager, DE2
Van den Eertwegh, AJM1
Incerti, E5
Gangemi, V1
Mapelli, P3
Deantoni, CL1
Giovacchini, G6
Fallanca, F1
Fodor, A5
Ciarmiello, A1
Baldari, S1
Gianolli, L4
Di Muzio, N4
Picchio, M9
Franzese, C1
Lopci, E1
Di Brina, L1
D'Agostino, GR1
Navarria, P1
Mancosu, P1
Tomatis, S1
Chiti, A1
Scorsetti, M1
Kim, SJ1
Koo, PJ1
Pak, K1
Kim, IJ1
Kim, K1
Metser, U1
Berlin, A1
Halankar, J1
Murphy, G1
Jhaveri, KS1
Ghai, S1
Tau, N1
Lancia, A1
Ceci, F3
Hoyer, M1
Jereczek-Fossa, BA2
Ost, P1
Castellucci, P4
Ingrosso, G1
Kitajima, K2
Yamamoto, S1
Odawara, S1
Kobayashi, K1
Fujiwara, M1
Kamikonya, N1
Fukushima, K1
Nakanishi, Y1
Hashimoto, T1
Yamada, Y1
Suzuki, T1
Kanematsu, A1
Nojima, M1
Yamakado, K1
Vaugier, L1
Palpacuer, C1
Rio, E1
Goineau, A1
Pasquier, D1
Buthaud, X1
De Laroche, G1
Beckendorf, V1
Sargos, P1
Créhange, G3
Pommier, P1
Loos, G1
Hasbini, A1
Latorzeff, I1
Silva, M1
Denis, F1
Lagrange, JL1
Campion, L1
Supiot, S1
Huang, SM1
Yin, L1
Yue, JL1
Li, YF1
Yang, Y1
Lin, ZC1
Schwarzenböck, SM1
Kurth, J1
Gocke, Ch1
Kuhnt, T1
Hildebrandt, G1
Krause, BJ6
Passoni, NM1
Suardi, N3
Abdollah, F2
Messa, C5
Freschi, M3
Montorsi, F3
Briganti, A3
Hodolič, M1
Maffione, AM1
Fettich, J1
Gubina, B1
Cimitan, M2
Rubello, D2
Wetter, A1
Lipponer, C1
Nensa, F1
Heusch, P1
Rübben, H1
Altenbernd, JC1
Schlosser, T1
Bockisch, A1
Pöppel, T1
Lauenstein, T1
Nagarajah, J1
Ahlgren, G2
Almquist, H2
Liedberg, F2
Lyttkens, K2
Ohlsson, T2
Bratt, O2
Heck, MM2
Souvatzoglou, M5
Retz, M1
Nawroth, R1
Kübler, H3
Maurer, T3
Thalgott, M1
Gramer, BM1
Weirich, G4
Rondak, IC1
Rummeny, EJ2
Schwaiger, M4
Gschwend, JE2
Krause, B1
Eiber, M3
Schiavina, R5
Concetti, S1
Brunocilla, E2
Nanni, C2
Borghesi, M1
Gentile, G1
Cevenini, M1
Bianchi, L2
Molinaroli, E1
Fanti, S5
Martorana, G4
Murphy, RC1
Nathan, MA2
Froemming, AT1
Hagen, CE1
Takahashi, N1
Kawashima, A1
Jilg, CA3
Schultze-Seemann, W2
Drendel, V1
Vach, W3
Wieser, G2
Krauss, T2
Jandausch, A1
Hölz, S1
Henne, K3
Reske, SN3
Grosu, AL3
Weber, WA1
Rischke, HC3
Berardi, G2
Busnardo, E3
Crivellaro, C1
Fiorino, C3
Kirienko, M3
Lépinoy, A1
Cochet, A2
Cueff, A1
Cormier, L2
Martin, E1
Maingon, P1
Bosset, JF1
Brunotte, F2
Garcia, JR2
Jorcano, S1
Soler, M2
Linero, D1
Moragas, M2
Riera, E1
Miralbell, R2
Lomeña, F1
Vag, T1
Beer, AJ2
Holzapfel, K2
Leifert, A1
Schnell, D1
Kirste, S1
Volegova-Neher, N2
Schlager, D1
Murphy, CR1
Bergstralh, EJ1
DiMonte, G1
Cheville, JC1
Lowe, VJ2
Mynderse, LA2
Kanoun, S1
Humbert, O1
Walker, PM1
Graziani, T2
Pultrone, C2
Eugenio, B1
Colletti, PM1
Beheshti, M2
Kunit, T1
Haim, S1
Zakavi, R1
Schiller, C1
Stephens, A1
Dinkelborg, L1
Langsteger, W3
Loidl, W2
Goldstein, J1
Even-Sapir, E1
Ben-Haim, S1
Saad, A1
Spieler, B1
Davidson, T1
Berger, R1
Weiss, I1
Appel, S1
Lawrence, YR1
Symon, Z1
Romera, N1
Cozar, M1
Escobar, M1
Evangelista, L3
Zattoni, F5
Guttilla, A2
Saladini, G1
Van den Bergh, L2
Lerut, E2
Haustermans, K2
Deroose, CM2
Oyen, R2
Isebaert, S1
Budiharto, T2
Ameye, F2
Mottaghy, FM2
Bogaerts, K2
Van Poppel, H2
Joniau, S2
Pinaquy, JB2
Fernandez, P1
Pasticier, G2
Parrens, M1
De Clermont, H2
Allard, JB1
Cornelis, F1
Verwer, EE1
van den Eertwegh, AJ1
van Moorselaar, RJ1
Windhorst, AD1
Schwarte, LA1
Hendrikse, NH1
Schuit, RC1
Lammertsma, AA1
Boellaard, R1
Piccardo, A1
Massollo, M1
Bandelloni, R1
Arlandini, A1
Foppiani, L1
Alongi, P1
Eiberger, AK1
Zanoni, L1
Lodi, F2
Malizia, C1
Ferrari, M1
Rigatti, P4
Fonti, C1
Hegemann, NS1
Wenter, V1
Spath, S1
Kusumo, N1
Li, M3
Bartenstein, P3
Fendler, WP1
Stief, C1
Belka, C1
Ganswindt, U1
Dell'Oca, I1
Cozzarini, C1
Mangili, P1
Pasetti, M1
Calandrino, R1
Di Muzio, NG1
Polverari, G1
Lima, GM1
Morganti, AG1
Ardizzoni, A1
Novara, G1
Lowe, V1
Schwenck, J1
Rempp, H1
Reischl, G1
Kruck, S1
Stenzl, A1
Nikolaou, K1
Pfannenberg, C1
la Fougère, C1
Hugentobler, A1
Gilbeau, L1
Talbot, JN1
Gauthé, M1
Beauregard, JM1
Beaulieu, A1
Parker, WP1
Evans, JD1
Stish, BJ1
Park, SS1
Olivier, K1
Choo, R1
Welch, BT1
Pisansky, TM1
Davis, BJ1
Van den Broeck, B1
De Maeseneer, D1
De Gersem, R1
De Man, K1
Rinnab, L1
Simon, J1
Volkmer, BG1
de Petriconi, R1
Hautmann, RE1
Wittbrodt, M1
Egghart, G1
Moeller, P1
Blumstein, N1
Reske, S1
Kuefer, R1
Samanes Gajate, AM1
Fazio, F3
Payne, GS1
Schmidt, M1
Morgan, VA1
Giles, S1
Bridges, J1
Ind, T1
DeSouza, NM1
Steuber, T1
Schlomm, T1
Heinzer, H1
Zacharias, M1
Ahyai, S1
Chun, KF1
Haese, A1
Klutmann, S1
Köllermann, J1
Sauter, G1
Mester, J1
Mikecz, P1
Fisch, M1
Huland, H1
Graefen, M1
Salomon, G1
Poulsen, MH2
Bouchelouche, K2
Gerke, O2
Petersen, H2
Svolgaard, B1
Marcussen, N2
Svolgaard, N2
Ogren, M1
Høilund-Carlsen, PF2
Geertsen, U2
Walter, S2
Winter, A1
Uphoff, J1
Henke, RP1
Wawroschek, F1
Ganter, C1
Wester, HJ1
Gaa, J1
Yeung, DK3
Fong, KY1
Chan, QC1
King, AD2
Dundee, PE1
Hutton, AC1
Eden, CG1
Jansen, JF1
Schöder, H2
Lee, NY1
Stambuk, HE1
Wang, Y1
Fury, MG1
Patel, SG1
Pfister, DG1
Shah, JP1
Koutcher, JA1
Shukla-Dave, A1
Beltramo, G1
Fariselli, L1
Fodor, C1
Santoro, L1
Vavassori, A1
Zerini, D1
Gherardi, F1
Ascione, C1
Bossi-Zanetti, I1
Mauro, R1
Bregantin, A1
Bianchi, LC1
De Cobelli, O1
Orecchia, R1
Mottaghy, F1
Würschmidt, F1
Petersen, C1
Wahl, A1
Dahle, J1
Kretschmer, M1
Pürschel, A1
Thamm, R1
Schuster, T1
Buck, AK1
Zimmermann, F1
Molls, M1
Geinitz, H1
Zengerling, F1
Schrader, AJ1
Schrader, M1
Jentzmik, F1
Da Pozzo, LF1
Tutolo, M1
Villa, L1
Gallina, A1
Capitanio, U1
Scattoni, V3
Colombo, R1
Guazzoni, G1
Bauman, G1
Belhocine, T1
Kovacs, M1
Ward, A1
Rachinsky, I1
Contractor, K1
Challapalli, A1
Barwick, T1
Winkler, M1
Hellawell, G1
Hazell, S1
Tomasi, G1
Al-Nahhas, A1
Kenny, LM1
Tadrous, P1
Coombes, RC1
Aboagye, EO1
Mangar, S1
Graute, V1
Jansen, N1
Ubleis, C1
Seitz, M2
Hartenbach, M1
Scherr, MK1
Thieme, S1
Cumming, P1
Klanke, K1
Tiling, R1
Hacker, M2
Peng, Z2
Liu, Q4
Han, M1
Yao, S2
Opercan, K1
Schmidt, S1
Herrmann, K1
Stollfuss, J1
Haller, B1
Treiber, U1
Fortuin, AS1
Deserno, WM1
Meijer, HJ1
Jager, GJ1
Takahashi, S1
Debats, OA1
Schick, C1
van Oort, I1
Witjes, AJ1
Hoogeveen, YL1
van Lin, EN2
Barentsz, JO2
Steffansen, SI1
Vees, H1
Steiner, C1
Dipasquale, G1
Chouiter, A1
Zilli, T1
Velazquez, M1
Namy, S1
Ratib, O1
Buchegger, F1
Tilki, D1
Reich, O1
Graser, A1
Silchinger, J1
Becker, AJ1
Khoder, W1
Stief, CG1
Muzzio, PC1
Sun, J1
Yang, WT1
Tse, GM2
de Jong, IJ1
Pruim, J2
Elsinga, PH2
Vaalburg, W2
Mensink, HJ1
Khan, N1
Oriuchi, N1
Zhang, H1
Higuchi, T1
Tian, M1
Inoue, T1
Sato, N1
Endo, K1
Ahuja, AT1
Leung, SF1
van Hasselt, AC1
Heinisch, M1
Fogelman, I1
Maeda, T2
Tateishi, U2
Komiyama, M1
Fujimoto, H1
Watanabe, S1
Terauchi, T2
Moriyama, N2
Arai, Y1
Sugimura, K1
Kakizoe, T2
Häcker, A1
Jeschke, S1
Leeb, K1
Prammer, K1
Ziegerhofer, J1
Sega, W1
Janetschek, G1
Lu, H1
Liu, PF1
Bao, RX1
Sun, F1
Bochner, B1
Oyama, N1
Roscigno, M1
Da Pozzo, L1
Bocciardi, A1
Heijmink, SW1
Scheenen, TW1
Fütterer, JJ1
Klomp, DW1
Heesakkers, RA1
Hulsbergen-van de Kaa, CA1
Heerschap, A1
Kanou, D1
Daisaki, H1
Moriya, Y1
Greco, C1
Cascini, GL1
Tamburrini, O1
Sardanelli, F1
Fausto, A1
Podo, F1
Chen, JH1
Baek, HM1
Nalcioglu, O1
Su, MY1
Chun, FK1
Corti, B1
Franceschelli, A1
Sanguedolce, F1
Bertaccini, A1
Farsad, M1
Grigioni, WF1
Star-Lack, J1
Spielman, D1
Adalsteinsson, E2
Kurhanewicz, J1
Terris, DJ2
Vigneron, DB1
Malycha, P1
Mountford, C1
Star-Lack, JM1
Adam, MF1
Pinto, HA1
Brown, JM1
Spielman, DM1
Hara, T1
Inagaki, K1
Kosaka, N1
Morita, T1
Kotzerke, J1
Prang, J1
Neumaier, B1
Volkmer, B1
Guhlmann, A1
Kleinschmidt, K1
Hautmann, R1
Pieterman, RM1
Que, TH1
van Putten, JW1
Willemsen, AT1
Groen, HJ1

Clinical Trials (10)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy[NCT04234399]22 participants (Actual)Observational2020-03-01Active, not recruiting
A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658]Phase 389 participants (Anticipated)Interventional2023-05-08Recruiting
BEACON - A Phase I/II Study of High-dose-rate Brachytherapy and External Beam and Short-term Androgen Deprivation COmbined for the Treatment of Men With Fluciclovine PET Pelvic Nodal Uptake in Locally Recurrent Prostate Cancer After Prior Definitive Radio[NCT03553602]Phase 1/Phase 224 participants (Anticipated)Interventional2018-05-29Recruiting
Pilot Comparative Study of PET/MR and PET/CT With Different Tracers (18F-FDG and 68Gallium Citrate) in the Diagnosis of Periprosthetic Joint Infection[NCT02855190]30 participants (Anticipated)Interventional2016-01-31Recruiting
Phase III Multicentre Prospective Comparative Study of Detection Rate of 18F-JK-PSMA-7 and of 18F-fluorocholine in Patients With Biochemical Recurrence of Prostate Cancer After Previous Treatment With Curative Intent[NCT05622162]Phase 3106 participants (Anticipated)Interventional2022-11-30Not yet recruiting
Evaluation of [18F] Fluorocholine PET/CT for Detection of Regional Lymph Node Metastases From Prostate Cancer[NCT00670527]205 participants (Anticipated)Interventional2008-01-31Recruiting
All-in-One Prostate Cancer Staging With MRI[NCT06071195]400 participants (Anticipated)Observational2021-12-22Recruiting
Clinical Value of [18]Fluoroethylcholine Positron-Emission-Tomography Combined With Endorectal Magnetic Resonance Imaging by Software Fusion for Pre-therapeutic Staging of Prostate Cancer[NCT00520546]Phase 344 participants (Actual)Interventional2007-12-31Completed
F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide[NCT01981707]Phase 2/Phase 312 participants (Actual)Interventional2013-12-31Terminated (stopped due to enrollment default)
A Phase 1 Pilot Study of 99mTc-MIP-1404 Single Photon Emission Computed Tomography (SPECT)/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection (PLND)[NCT01572701]Phase 18 participants (Actual)Interventional2012-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Lesion Based Analysis of FEC-PET, Endorectal MRI and Combined FEC-PET/eMRI in All Patients

PET positive lesions (n=128) were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI

,,
Interventionlesions (Number)
True positiveFalse positiveTrue negativeFalse negativeTotal trueTotal false
FEC-PET592619247850
Magnetic Resonance Imaging (MRI)402718435870
PET/MRI55837289236

Lesion Based Analysis of FEC-PET, Endorectal MRI and Combined FEC-PET/eMRI in Patients With Gleason Score >6 (3+3)

PET positive lesions in patients with Gleason >6(3+3),n=43 were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative & positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI

,,
Interventionlesions (Number)
True positiveFalse positiveTrue negativeFalse negativeTotal trueTotal false
FEC-PET27583358
Magnetic Resonance Imaging (MRI)229482617
PET/MRI271114385

Lesion Based Analysis of FEC-PET, Endorectal MRI and Combined FEC-PET/eMRI in Patients With Malignant Lesions >5mm (n=98)

PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined without malign lesions <=5mm. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI

,,
Interventionlesions (Number)
True positiveFalse positiveTrue negativeFalse negativeTotal trueTotal false
FEC-PET48241886632
Magnetic Resonance Imaging (MRI)372616195345
PET/MRI48832108018

Number of Participants With Positive or Negative Results in PET, MRI or PET/MRI for Prostate Cancer Compared to Histological Findings

PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. At least 1 histological confirmed cancer lesion has to be detected by each of the 3 methods to be patient based true positive. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI

,,
Interventionparticipants (Number)
True PositiveFalse PositiveTrue NegativeFalse NegativeTotal TrueTotal False
[18F]Fluoroethylcholine Positron-Emission-Tomography (FEC-PET)36101362
Magnetic Resonance Imaging (MRI)2610112711
PositronEmissionTomography/MagneticResonanceImaging (PET/MRI)35012362

Reviews

13 reviews available for choline and Lymph Node Metastasis

ArticleYear
Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer.
    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2022, Dec-27, Volume: 94, Issue:4

    Topics: Choline; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Pos

2022
Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.
    World journal of urology, 2018, Volume: 36, Issue:3

    Topics: Acetates; Carbon; Carbon Radioisotopes; Carcinoma, Transitional Cell; Choline; Humans; Likelihood Fu

2018
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer.
    World journal of urology, 2019, Volume: 37, Issue:12

    Topics: Choline; Fluorine Radioisotopes; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymphatic Metastas

2019
Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.
    Medicine, 2018, Volume: 97, Issue:50

    Topics: Aged; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron

2018
Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40 Suppl 1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positro

2013
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:5-6

    Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglu

2014
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
    Nuclear medicine communications, 2016, Volume: 37, Issue:12

    Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positr

2016
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Aktuelle Urologie, 2012, Volume: 43, Issue:1

    Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Disease Progression; Fluorine Radioisotopes; Humans;

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
    Prostate cancer and prostatic diseases, 2012, Volume: 15, Issue:1

    Topics: Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplas

2012
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
    European urology, 2013, Volume: 63, Issue:6

    Topics: Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Nodes; Lymphatic Metastasis; Ma

2013
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
    Seminars in nuclear medicine, 2006, Volume: 36, Issue:1

    Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeo

2006
Is there a role for positron emission tomography imaging in the early evaluation of prostate cancer relapse?
    Prostate cancer and prostatic diseases, 2008, Volume: 11, Issue:2

    Topics: Adenocarcinoma; Carbon Radioisotopes; Choline; Clinical Trials as Topic; Humans; Lymphatic Metastasi

2008
MR spectroscopy of the breast.
    La Radiologia medica, 2008, Volume: 113, Issue:1

    Topics: Breast; Breast Neoplasms; Choline; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging;

2008

Trials

8 trials available for choline and Lymph Node Metastasis

ArticleYear
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).
    International journal of radiation oncology, biology, physics, 2019, 04-01, Volume: 103, Issue:5

    Topics: Aged; Androgen Antagonists; Choline; Digestive System; Dose Fractionation, Radiation; Fluorine Radio

2019
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
    Molecular imaging and biology, 2015, Volume: 17, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic

2015
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
    Radiation oncology (London, England), 2011, May-01, Volume: 6

    Topics: Aged; Carcinoma; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Sta

2011
Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Clinical lung cancer, 2012, Volume: 13, Issue:4

    Topics: Adult; Aged; Carbon Radioisotopes; Choline; Contrast Media; Female; Humans; Lung Neoplasms; Lymph No

2012
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
    Nuclear medicine communications, 2003, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline

2003
Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    The Journal of urology, 2006, Volume: 176, Issue:5

    Topics: Aged; Choline; Humans; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomog

2006
In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:1

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Choline; Creatine; Head and Neck Neoplasms; Humans; Lactic Ac

2000

Other Studies

82 other studies available for choline and Lymph Node Metastasis

ArticleYear
Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [
    Clinical physiology and functional imaging, 2022, Volume: 42, Issue:6

    Topics: Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomogr

2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
    The Journal of urology, 2022, Volume: 208, Issue:6

    Topics: Androgen Antagonists; Androgens; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, L

2022
A retrospective study assessing the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node
    Scandinavian journal of urology, 2021, Volume: 55, Issue:4

    Topics: Choline; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Pos

2021
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
    Clinical genitourinary cancer, 2017, Volume: 15, Issue:5

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Choline; Combined Mo

2017
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.
    Current radiopharmaceuticals, 2017, Nov-10, Volume: 10, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis

2017
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer.
    Cancer investigation, 2017, Oct-21, Volume: 35, Issue:9

    Topics: Aged; Carbon Radioisotopes; Choline; Disease-Free Survival; Humans; Kallikreins; Kaplan-Meier Estima

2017
    AJR. American journal of roentgenology, 2018, Volume: 210, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mi

2018
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
    Acta medica Okayama, 2018, Volume: 72, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma

2018
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.
    Urologic oncology, 2014, Volume: 32, Issue:1

    Topics: Aged; Androgen Antagonists; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymph Nodes;

2014
Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:9

    Topics: Choline; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission

2013
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance I

2014
¹⁸F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
    World journal of urology, 2014, Volume: 32, Issue:4

    Topics: Aged; Biomarkers, Tumor; Choline; Cohort Studies; Fluorine Radioisotopes; Humans; Lymph Node Excisio

2014
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging;

2014
First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches.
    Urologia internationalis, 2014, Volume: 92, Issue:2

    Topics: Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Humans; Lymph Node Excision; Lymphati

2014
Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Area Under Curve; Carbon Radioisotopes; Choline; Humans; Image Processing,

2014
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography.
    The Journal of urology, 2014, Volume: 192, Issue:1

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplas

2014
(11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:7

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Feasibility Studies; Humans; Lymphatic Metas

2014
Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 111, Issue:1

    Topics: Choline; Fluorine Radioisotopes; Humans; Kallikreins; Lymph Nodes; Lymphatic Metastasis; Male; Multi

2014
11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2015, Volume: 59, Issue:3

    Topics: Aged; Biopsy; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Mid

2015
Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
    European radiology, 2014, Volume: 24, Issue:8

    Topics: Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; Lymph Nodes; Lymp

2014
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.
    Radiation oncology (London, England), 2014, Aug-12, Volume: 9

    Topics: Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymphatic

2014
Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
    The Journal of urology, 2015, Volume: 193, Issue:1

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle

2015
11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Choline; Female; Humans; Lymphatic

2015
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    American journal of clinical oncology, 2017, Volume: 40, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Brachytherapy; Carbon Radioisotopes; Choline; Humans; Lymph

2017
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Actas urologicas espanolas, 2015, Volume: 39, Issue:4

    Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly

2015
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A
    Scandinavian journal of urology, 2015, Volume: 49, Issue:5

    Topics: Abdomen; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Nod

2015
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
    Urologic oncology, 2015, Volume: 33, Issue:3

    Topics: Aged; Biopsy; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; Lymph Nod

2015
Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:4

    Topics: Adenocarcinoma; Anthracosis; Choline; False Positive Reactions; Humans; Lymphatic Metastasis; Male;

2015
Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:4

    Topics: Adenocarcinoma; Aged; Choline; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emis

2015
Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:3

    Topics: Aged; Calibration; Choline; Humans; Kinetics; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged;

2015
Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:8

    Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Pos

2015
Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Disease-Free Survival; Female; Humans; Image

2015
PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
    Advances in medical sciences, 2016, Volume: 61, Issue:2

    Topics: Aged; Choline; Cohort Studies; Contrast Media; Disease Progression; Follow-Up Studies; Humans; Lymph

2016
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment.
    Radiation oncology (London, England), 2016, Mar-11, Volume: 11

    Topics: Aged; Aged, 80 and over; Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neop

2016
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
    BJU international, 2017, Volume: 119, Issue:3

    Topics: Aged; Aged, 80 and over; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imagin

2017
(11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:11

    Topics: Aged; Aged, 80 and over; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Lymphat

2016
Comparison of
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotop

2017
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:1

    Topics: Aged; Breast Neoplasms, Male; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; P

2017
How we read FCH-PET/CT for prostate cancer.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Dec-06, Volume: 16, Issue:1

    Topics: Aged; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; M

2016
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
    International journal of radiation oncology, biology, physics, 2017, 03-01, Volume: 97, Issue:3

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged

2017
Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:4

    Topics: Adenoma; Carcinoma; Choline; Diagnosis, Differential; Humans; Lymphatic Metastasis; Male; Middle Age

2017
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
    Urologia internationalis, 2008, Volume: 81, Issue:2

    Topics: Aged; Biomarkers; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neo

2008
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:11

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Diagnosis, Differential; Fe

2008
Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.
    Gynecologic oncology, 2010, Volume: 116, Issue:2

    Topics: Adult; Aged; Biomarkers, Tumor; Cell Differentiation; Choline; Cohort Studies; Diffusion Magnetic Re

2010
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
    European journal of cancer (Oxford, England : 1990), 2010, Volume: 46, Issue:2

    Topics: Choline; False Negative Reactions; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Positron

2010
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
    BJU international, 2010, Volume: 106, Issue:5

    Topics: Aged; Choline; Epidemiologic Methods; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged;

2010
First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy.
    Urologia internationalis, 2010, Volume: 84, Issue:4

    Topics: Aged; Carbon Radioisotopes; Choline; Feasibility Studies; Germany; Humans; Lymph Node Excision; Lymp

2010
Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
    Molecular imaging and biology, 2011, Volume: 13, Issue:2

    Topics: Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans

2011
Chemical shift imaging in the head and neck at 3T: initial results.
    Journal of magnetic resonance imaging : JMRI, 2010, Volume: 32, Issue:5

    Topics: Adult; Aged; Choline; Female; Head; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assi

2010
[¹⁸F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
    BJU international, 2011, Volume: 107, Issue:1

    Topics: Choline; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Prostatic Ne

2011
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
    International journal of radiation oncology, biology, physics, 2012, Jan-01, Volume: 82, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squam

2012
Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carbon Radioisotopes; Choline; Disease-Free Survival;

2012
Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    European urology, 2011, Volume: 60, Issue:1

    Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance Imaging; Humans; L

2011
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:2

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Logistic Models; Lymphatic Metastasis; Male; Middle Age

2011
Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
    European urology, 2011, Volume: 60, Issue:5

    Topics: Aged; Choline; Disease-Free Survival; Feasibility Studies; Humans; Italy; Kaplan-Meier Estimate; Lym

2011
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24

    Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Choline Kinase; Humans; Immunohistochemistry

2011
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:2

    Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymph

2012
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
    European urology, 2012, Volume: 61, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Choline; Cystectomy; Female; Humans

2012
Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases.
    International journal of radiation oncology, biology, physics, 2012, Nov-01, Volume: 84, Issue:3

    Topics: Aged; Carbon Radioisotopes; Choline; Contrast Media; Dextrans; Humans; Lymph Nodes; Lymphatic Metast

2012
Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    BJU international, 2012, Volume: 110, Issue:10

    Topics: Aged; Bone Neoplasms; Choline; Fluorides; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male

2012
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    BJU international, 2012, Volume: 110, Issue:11

    Topics: Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Lym

2012
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
    Radiation oncology (London, England), 2012, Aug-08, Volume: 7

    Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lym

2012
18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
    European urology, 2013, Volume: 63, Issue:5

    Topics: Aged; Choline; Disease Progression; Humans; Kallikreins; Lymph Node Excision; Lymph Nodes; Lymphatic

2013
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
    Oncology reports, 2013, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine;

2013
Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
    Radiology, 2002, Volume: 225, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast;

2002
Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:3

    Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Choline; Humans; Image Processing, Computer-Assisted; Ly

2003
In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma.
    AJNR. American journal of neuroradiology, 2004, Volume: 25, Issue:3

    Topics: Adult; Aged; Algorithms; Choline; Creatine; Data Interpretation, Statistical; Energy Metabolism; Equ

2004
Distant metastasis of prostate cancer: early detection of recurrent tumor with dual-phase carbon-11 choline positron emission tomography/computed tomography in two cases.
    Japanese journal of clinical oncology, 2006, Volume: 36, Issue:9

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Carbon Radioisotopes; Choline; Early Diagnosi

2006
Evaluation of spectral selected press sequence in breast lesion characterization.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2006, Volume: 21, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Fibroa

2006
Detection and management of isolated lymph node recurrence in patients with PSA relapse.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Prosta

2007
Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Aged; Choline; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurr

2007
Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
    Investigative radiology, 2007, Volume: 42, Issue:6

    Topics: Adenocarcinoma; Aged; Choline; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lym

2007
A case of colon cancer detected by carbon-11 choline positron emission tomography/computed tomography: an initial report.
    Japanese journal of clinical oncology, 2007, Volume: 37, Issue:10

    Topics: Adenocarcinoma; Biopsy; Carbon Radioisotopes; Choline; Colonic Neoplasms; Female; Humans; Hysterecto

2007
Estrogen receptor and breast MR imaging features: a correlation study.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:4

    Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Humans; Lymphatic

2008
Editorial comment on: 11C-choline-positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    European urology, 2008, Volume: 54, Issue:2

    Topics: Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Nomograms; Posi

2008
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    European urology, 2008, Volume: 54, Issue:2

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Stagi

2008
In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors.
    Journal of magnetic resonance (San Diego, Calif. : 1997), 1998, Volume: 133, Issue:2

    Topics: Aspartic Acid; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Female; Humans; Lactic Acid; Lip

1998
Magnetic resonance spectroscopy and breast cancer.
    The Australian and New Zealand journal of surgery, 1998, Volume: 68, Issue:12

    Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Choline; Creatine; F

1998
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:9

    Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Choline; Female; Fluorodeoxygluco

2000
Experience with carbon-11 choline positron emission tomography in prostate carcinoma.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:9

    Topics: Aged; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neop

2000
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:2

    Topics: Aged; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung N

2002